3.High expression of the foot-and-mouth disease's structural protein P1 in Escherichia coli and analysis of its biology activity.
Xiao-Lan YU ; Shao-Bo XIAO ; Liu-Rong FANG ; Meng-Yu HU ; Lin YAN ; Xiao-Hui DONG ; Huan-Chun CHEN
Chinese Journal of Biotechnology 2005;21(1):163-166
Foot-and-mouth disease virus (FMDV) is the aetiological angent of a highly contagious viral disease. The complete gene encoding the structural protein of FMDV (P1) was subcloned into expression vector pGEX-KG, resulting in the fusion expression plasmid pKG-P1. After transformed into E. coli BL21(DE3) and induced by IPTG, the results of SDS-PAGE showed that the GST-P1 fusion protein was expressed in high level. The molecular weight of the fusion protein wa 110kD and the expressed products were soluble. Western-blotting was performed to confirm that the expressed fusion protein could specifically react with antiserum against FMDV. The fusion proteins were further purified by GST purification kit and an indirect ELISA (P1-ELISA) based on the purified proteins was developed. Comparison between P1-ELISA and the standard indirect haemagglutinin assay showed the two methods had 87 per cent agreement by detecting 864 serum samples, indicating the purified P1 protein was specific as the antigen of indirect P1-ELISA.
Capsid Proteins
;
biosynthesis
;
genetics
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Foot-and-Mouth Disease Virus
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
4.Construction, expression and immunogenicity analysis of a Tat N-terminus-deleted mutant fusion protein of human immunodeficiency virus type 1.
Hua-Qun ZHANG ; Wen-Ting LIAO ; Qiu-Li CHEN ; Yi-Bing GE ; Jie YANG ; Ping-Ping ZHANG ; Pei-Pei QI ; Chao LIU ; Ting HE ; Jin-Hong WANG ; Wei PAN ; Jie CAO
Chinese Journal of Virology 2011;27(6):580-586
In the study, a gene encoding Tat protein N terminal 1- 21 amino acid residues-deleted mutant (Tat22-101) was amplified by PCR from a full length Tat gene of human immunodeficiency virus type 1, and the prokaryotic expression plasmid pET32a-Tat22-101 was constructed. After identification by digestion with endonucleases and sequencing, the recombinant plasmid pET32a-Tat22-101 was transformed into E. coli BL21(DE3) and expressed with IPTG induction. The mutant fusion protein with deleted Tat N terminal was purified by an affinity chromatography column Ni(2+)-NTA and subsequently identified by SDS-PAGE and Western blotting. The results showed that the molecular weight of the mutant protein was approximately 26.9kD. Furthermore, BALB/c mice were immunized with the mutant protein and the anti-sera were collected. ELISA results showed that the mutant protein preserved its immunogenicity, particularly it could improve the production of antibodies to other epitopes in addition to the N terminal epitope of Tat protein, which might provide some valuable information for the study of Tat functions as well as for development of potential novel HIV Tat vaccine.
Animals
;
Female
;
Gene Products, tat
;
biosynthesis
;
genetics
;
immunology
;
HIV-1
;
genetics
;
immunology
;
Humans
;
Mice
;
Mice, Inbred BALB C
;
Mutant Proteins
;
genetics
;
immunology
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
5.Prokaryotic expression and antigenicity of the CagA gene in Helicobacter pylori.
Xiong CHEN ; Canxia XU ; Fen WANG ; Shourong SHEN ; Yan JIA
Journal of Central South University(Medical Sciences) 2010;35(8):847-853
OBJECTIVE:
To synthesize the specific CagA gene segment of the gastric cancer idiotype Helicobacter pylori (H. pylori), establish the prokaryotic expression system and identify the antigenicity sequence of recombination signals.
METHODS:
We selected the CagA fragment which was related to gastric cancer in our earlier research. The CagA gene segment was optimized and synthesized. The synthesized CagA gene was cut from the pUC57-CagA plasmid and then was carried by expression vector pET32a to be transformed into the host bacterium BL21 (DE3). The positively cloned pET32a-CagA was selected by receptivity of aniline and colony PCR. The host bacterium with pET32a-CagA was induced by IPTG to express fusion protein. The expression of CagA protein was analyzed by SDS-PAGE gel electrophoresis and the antigenicity of fusion protein was examined by Western blot.
RESULTS:
CagA gene segment was designed and synthesized. The sequence of synthesis CagA gene segment was the same as the one designed before (AF289435). We successfully constructed the plasmid of prokaryotic expression of the pET32a-CagA. Homology of the target CagA proteinum was 100%, the same as AAG09884. The host bacterium BL21 (DE3) containing pET32a-CagA could express CagA fusion protein after the IPTG induction. SDS-PAGE gel electrophoresis showed that the molecular weight of fusion protein was the same as expected (45 kD). Western blot showed that the fusion protein could be combined with the antibody of the whole bacterium of anti-H. pylori.
CONCLUSION
The synthesized CagA fusion protein from the prokaryotic expression system has antigenicity. We hope to set the foundation for selecting the strain in H. pylori correlated to gastric cancer and corresponding therapy in clinical practice.
Amino Acid Sequence
;
Antigens, Bacterial
;
genetics
;
immunology
;
Bacterial Proteins
;
genetics
;
immunology
;
Base Sequence
;
Genetic Vectors
;
Helicobacter pylori
;
genetics
;
immunology
;
Molecular Sequence Data
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
6.Construction and immunogenicity of recombinant pseudorabies virus expressing the modified GP5m protein of porcine reproduction and respiratory syndrome virus.
Yun-Bo JIANG ; Liu-Rong FANG ; Shao-Bo XIAO ; Hui ZHANG ; Huan-Chun CHEN
Chinese Journal of Biotechnology 2005;21(6):858-864
Pseudorabies virus (PRV), an alpha-herpesvirus, has been used as a vector for live-viral animal vaccines. The recombinant PRV TK- / gE- / GP5+, which expressing GP5 of PRRSV, is developed based on the PRV genetic-depleting vaccine-virus strain, TK- / gE- /LacZ+. However, this strain stimulated poorly the vaccinated animals to produce neutralizing antibodies against PRRSV. In order to develop a booster specific immunized response of the PRV recombinant, the ORF5 gene of PRRSV TK- / gE- / LacZ+ was substituted by a modified ORF5 gene, ORF5m. The resultant recombinant PRV, TK- /gE- / GP5m+, was verified by PCR, Southern blotting and Western blotting. TK- / gE- / GP5m+ and TK- / gE- / GP5+ expressed GP5 proteins were inoculated into balb/c mice to evaluate their immunogenicity. The results demonstrated that the amount of neutralization antibodies and cell-immunity responses induced by TK- / gE- /GP5m+ against PRRSV were higher than that of TK- / gE- / GP5+. This study indicated that the new recombinant PRV expressing the modified GP5m protein is a candidate for the development of bivalent genetic engineering vaccines against PRRSV and PRV.
Animals
;
Genetic Vectors
;
Herpesvirus 1, Suid
;
genetics
;
immunology
;
Mice
;
Mice, Inbred BALB C
;
Porcine respiratory and reproductive syndrome virus
;
genetics
;
immunology
;
Recombinant Fusion Proteins
;
genetics
;
immunology
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
;
Swine
;
Viral Envelope Proteins
;
biosynthesis
;
genetics
;
Viral Vaccines
;
genetics
;
immunology
7.Fusion expression of Escherichia coli heat-labile enterotoxin B subunit gene and foot-and-mouth disease virus type O VP1 gene and immunogenicity analysis.
Runcheng LI ; Xinglong YU ; Xia BAI ; Weijun XIANG ; Meng GE ; Manxiang LI
Chinese Journal of Biotechnology 2009;25(4):560-565
LTB gene fragment was amplified by PCR from plasmid pMDTLT, and a recombinant plasmid pETLTBVP1 was constructed by inserting LTB gene fragment into VP1 gene expression plasmid pETVP1 constructed previously. The recombinant plasmids were transformed into E. coli BL21(DE3) and induced to express by IPTG. The recombinant protein existed in the inclusion body and its molecular weight was about 39 kD proved by SDS-PAGE analysis. Western blotting showed that the fusion protein could be reacted with both anti-FMDV and anti-cholera toxin serum demonstrating the immunoactivity of the fusion protein. Strong immune responses can be induced in mice inoculated with the fusion protein intraperitoneally, and the serum antibody level is higher than that of commercial foot-and-mouth disease vaccines.
Animals
;
Antibodies, Viral
;
blood
;
Bacterial Toxins
;
genetics
;
immunology
;
metabolism
;
Capsid Proteins
;
genetics
;
immunology
;
metabolism
;
Enterotoxins
;
genetics
;
immunology
;
metabolism
;
Escherichia coli
;
genetics
;
metabolism
;
Escherichia coli Proteins
;
Female
;
Gene Fusion
;
genetics
;
Mice
;
Plasmids
;
genetics
;
Recombinant Fusion Proteins
;
genetics
;
immunology
;
metabolism
8.Immune responses induced by recombinant adenovirus Ad5F35-LMP2 in rhesus monkeys.
Wu-Ning MO ; Ling ZHOU ; Xiao-Bing WU ; Zhan WANG ; An-Zhou TANG ; Guang-Wu HUANG ; Shuang-Qing YU ; Qi WANG ; Shu-Qing YE ; Hai-Jun DU ; Yi ZENG
Chinese Journal of Experimental and Clinical Virology 2007;21(3):226-228
OBJECTIVETo observe the specific cellular and humoral immune responses after immunization with recombinant adenovirus Ad5F35-LMP2 in rhesus monkeys.
METHODSSixteen rhesuses were immunized with Ad5F35-LMP2 through intra-muscular injection in three groups: high dosage group (1.5 x 10(10) TCID(50)/rhesus), medium dosage group (1.5 x 10(9)TCID(50)/rhesus), low dosage group (1.5 x 10(8)TCID50/rhesus) and the last group was control (PBS 4 ml/rhesus). They were totally immunized three times at intervals of one month. The EBV-LMP2 specific cellular immune responses were tested during the 0, 4, 8, 12 weeks by Elispot after immunization respectively. And the titers of anti-LMP2 antibody were tested by EIA at the same time.
RESULTSEBV-LMP2 specific cellular and humoral immune responses which were induced by recombinant adenovirus Ad5F35-LMP2 can be found in all the three dosage groups. The potency of immune responses was related with the dosage of immunization. Higher dosage elicited more potent immune response.
CONCLUSIONThe recombinant adenovirus Ad5F35-LMP2 could elicit LMP2 specific cellular and humoral immune responses in rhesus.
Adenoviruses, Human ; genetics ; Animals ; Cell Differentiation ; Herpesvirus 4, Human ; genetics ; Immunity, Cellular ; immunology ; Immunization ; methods ; Macaca mulatta ; Recombinant Fusion Proteins ; genetics ; immunology ; Viral Matrix Proteins ; genetics ; immunology
9.Soluble expression and characterization of disulfide bond-rich subdomains of membrane protein p185 in Escherichia coli.
Liang-Wei LI ; Hai-Bo LIU ; Si-Yi HU ; Dun LIANG ; Lian-Sheng CHENG ; Jing LIU
Chinese Journal of Biotechnology 2005;21(4):590-596
Transmembrane protein p185 (the product of Her2/c-erbB-2 gene) is a member of the epidermal growth factor receptor (EGFR) family. Its overexpression was found in about 30% of breast cancer. It is essential to obtain soluble extracellular domain (ECD) of p185, especially disulfide bond rich domains, for identifying the epitopes of anti-p185 antibodies and researching the interrelationship between the antigen and antibody. The disulfide bond rich domain I-II and domain IV of p185 ECD were amplified from plasmid pBabe/erbB-2 by PCR respectively. These two fragments were inserted into pGEX/4T-1 vector, transfected into E. coli Origami B (DE3) pLysS and expressed inductively by low concentration of IPTG and low temperature overnight. After the pressure lysis of cells, the supernatants were analyzed by SDS-PAGE and the result demonstrated that this GST-fusion protein was expressed solubly in the amount of 10-15 mg/L. By the ELISA, Western blot and other immunological assays, the fusion proteins and their GST cut-off derivates both showed binding activities with several anti-p185 antibodies respectively. These results indicated that it was a feasible and effectual method to express disulfide bond rich domain I-II and domain IV of p185 ECD and this method may also be used to express other disulfide bond rich proteins.
Antibodies, Monoclonal
;
immunology
;
Disulfides
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Genetic Vectors
;
genetics
;
Humans
;
Receptor, ErbB-2
;
biosynthesis
;
genetics
;
immunology
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
;
Solubility
;
Transfection
10.Preparation and characterization the polyclonal antibody of the nonstructural protein of human highly pathogenic H5N1 avian influenza viruses.
Pei-Yu JIANG ; Hui-Lian HUANG ; Hong-Chang ZHOU ; Bo-Ying XU ; Fu-Ping GU ; Li-Shan MIN ; Jing ZHONG ; Li-Cheng DAI
Chinese Journal of Experimental and Clinical Virology 2013;27(2):138-140
OBJECTIVEOf this study was to prepare high sensitivity and high specificity of highly pathogenic H5N1 subtype avian influenza virus NS1 protein antibody and a preliminary assessment of its potency.
METHODSConstruct pET-28a (+) recombinant vector containing the H5N1 subtype of avian influenza virus NS1 sequences of E. coli BL21 (DE3), induced expression of NS1 protein, NS1 recombinant protein was obtained by Ni-NTA column purified by affinity chromatography, and SDS-PAGE and Western Blot analysis. Purified protein antigen to immunize New Zealand white rabbits, obtained rabbit anti-NS1 serum, affinity-purified polyclonal antibodies. Using ELISA and Western Blot analysis of purified antibody titer and specificity.
RESULTSNS1 fusion protein was highly expressed in a purity of greater than 90%, with the fusion protein was used to immunize New Zealand white rabbits anti-NS1 polyclonal antibody titer of 1:80 000, and specific recognition of the H5N1 subtype of avian influenza virus NS1 protein.
CONCLUSIONSNS1 polyclonal antibodies to NS1 recombinant protein purified antigen, with better potency and specificity, and to prepare the conditions for the development of the H5N1 subtype of avian influenza virus detection kit.
Animals ; Antibodies, Viral ; biosynthesis ; immunology ; Escherichia coli ; genetics ; Influenza A Virus, H5N1 Subtype ; immunology ; Rabbits ; Recombinant Fusion Proteins ; immunology ; isolation & purification ; Viral Nonstructural Proteins ; genetics ; immunology